GDF materials:
- GDF Medicines Catalog
- GDF Medicines Ordering List
- GDF Diagnostics, Medical Devices & Other Health Products Catalog
- GDF Diagnostics, Medical Devices & Other Health Products Ordering List
- GDF Step by Step guide on electronic order managemnet(trilingual guide - English, Français, Español)
- GDF Quality Assurance Policy
- GDF Drug Monitoring Programme
- Technical Information Note on Determine TB LAM Ag test
- Technical Information Note on Loopamp (LAMP) test
- Technical Information Note on GDF Smear microscopy kits
- TB Medicines Dashboard
- Pediatric DR-TB initiative
Treatment of TB:
- 2017 WHO Update: Guidelines for Treatment of drug-susceptible tuberculosis and patient care
- 2021 WHO Rapid Communication: Treatment of drug-susceptible tuberculosis
- 2019 WHO Consolidated guidelines on drug-resistant tuberculosis treatment
- 2020 WHO Consolidated guidelines on tuberculosis, drug-resistant ruberculosis treatment
- 2018 WHO Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management
- 2020 WHO Consolidated guidelines on tuberculosis: Tuberculosis preventive treatment
Treatment of TB in Children:
- 2014 WHO Guidance on the Management of Tuberculosis in Children
- 2017 WHO Statement on the Use of Child-friendly Fixed-dose Combinations for the Treatment of TB in Children
- 2016 GDF, WHO, Global Fund Technical Briefing Note to Switch to New Paediatric TB Formulations
- 2016 WHO Interim Policy Guidance: The Use of Delamanid in the Treatment of Multidrug-resistant Tuberculosis in Children and Adolescents
- Sentinel/GDF Management of Multidrug-Resistant Tuberculosis in Children: A Field Guide
- English
- русский
- Sentinel/GDF Standard Operating Procedures for Administration of Dispersible Formulations of Second-Line Drugs For Clinical/Nursing Personnel
- Sentinel/GDF Drug Sheets for Dispersible Formulations
- Sentinel/GDF DR-TB & Me: Caring for a child with drug resistant TB
- Sentinel/GDF Standard Operating Procedures for Storage and Administration of Dispersible Formulations of Second-Line Drugs for Pharmacy Personnel
- Sentinel/GDF Pediatric Formulations of Second-Line Drugs for the Treatment of Drug-Resistant Tuberculosis
- English
- русский
- Sentinel/GDF Summary Points on Pediatric Formulations of Second-Line Drugs for Tuberculosis /
TB Diagnostics:
- 2021 WHO Consolidated guidelines on tuberculosis: Rapid diagnostics for tuberculosis detection (update)
- 2016 WHO Framework of Indicators and Targets for Laboratory Strengthening Under the End TB Strategy, including spreadsheet for calculating diagnostic testing and facility needs
- 2017 GLI Model TB Diagnostic Algorithms
- 2017 GLI Practical Guide to TB Laboratory Strengthening
- Global Laboratory Initiative
Quantification & Pricing:
- QuanTB
- Global Fund PSM Plan
- Health Product Management Template
- Health Product Management Template User Guide:
- Guide to Global Fund's Policies on Procurement and Supply Management
- Global Fund List of Tuberculosis Pharmaceutial Products
- Global Fund Quality Assurance Policy
- Global Fund List of Countries with Stringent Regulatory Authorities
Please visit The Global Fund's website for more information on PSM development.